Sven Dethlefs

Sven Dethlefs (Ph.D) became Executive Vice President, North America Commercial in August 2021, leading all commercial activities of Teva USA and Teva Canada’s Generic and Specialty businesses.

Headquartered in Parsippany, NJ, Teva USA’s generic medicines saved the US healthcare system $28.8B in 2020 alone, and in the US, 10 prescriptions are filled with a Teva product every second. Teva USA maintains leadership positions with broad generic and specialty portfolios across varying therapeutic conditions, including movement disorders, mental health and respiratory. Teva Canada, headquartered in Toronto, has provided affordable healthcare solutions to Canadians for over 50 years, with currently more than 179,000 prescriptions filled each day.

Sven Dethlefs has been part of Teva’s Executive Management team since 2017, where he served as Executive Vice President, Global Marketing and Portfolio, assuming responsibility for International Markets, Commercial in 2021. He also held leadership roles in Teva’s Global Specialty business, Commercial European business and Global Operations (TGO). Sven has played an integral role in optimizing Teva's vast global portfolio, in developing the R&D pipeline strategy, and leading global marketing teams.

Sven joined Teva as General Manager, Teva Germany in 2008. Prior to joining Teva, he served for over eleven years as a partner at McKinsey & Company.

Sven received his Ph.D. in biochemistry from the FU Berlin/Pasteur Institute Paris.